GlassScriptPhysician profile
Thekla Bacharach
NPI 1225442171
$24,358.23
in general payments reported to CMS, 2019-2025
33 companies · $1,150 in 2025
The $1,150 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,016 · 2020: $7,994 · 2021: $3,715 · 2022: $3,125 · 2023: $2,182 · 2024: $3,176 · 2025: $1,150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,911 · Consulting Fee: $1,200 · Travel and Lodging: $397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,910.60 |
| Consulting Fee | $1,200.00 |
| Travel and Lodging | $397.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $7,169.23 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $4,133.10 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Excluder Thoracoabdominal Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Medtronic, INC. | $2,249.30 | 2021-2025 | Venaseal, Corevalve Evolut R, Heli-Fx Endoanchor System |
| Silk Road Medical, INC. | $1,883.93 | 2020-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Shape Memory Medical INC. | $1,851.90 | 2023-2025 | Impede Embolization Plug |
| Inari Medical, INC. | $1,829.90 | 2021-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abbott Laboratories | $530.65 | 2021-2025 | Esprit, Acculink |
| Bolton Medical INC | $530.33 | 2020-2025 | Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System |
| Bard Peripheral Vascular, INC. | $497.66 | 2021-2024 | Crosser Iq, Venovo |
| Penumbra, INC. | $422.51 | 2020-2023 | Indigo System |
| Cardinal Health 200 LLC | $396.60 | 2020-2021 | |
| Cook Medical LLC | $391.32 | 2023-2025 | Zenith Spiral-Z, Zenith |
| Inspiremd LTD | $377.00 | 2024 | Cguard |
| Cordis US Corp. | $343.20 | 2021-2022 | |
| Lemaitre Vascular, INC. | $263.10 | 2023-2024 | Artegraft Vascular Graft, Xenosure Biologic Patch |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $230.28 | 2021-2022 | |
| Endologix LLC | $221.69 | 2020-2021 | |
| Boston Scientific Corporation | $133.44 | 2019-2025 | Enroute Transcarotid Stent |
| Philips North America LLC | $124.92 | 2019-2022 | |
| Stryker Corporation | $112.09 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Reflow Medical INC | $105.48 | 2025 | |
| Terumo Medical Corporation | $98.45 | 2022 | |
| Janssen Pharmaceuticals, INC | $79.93 | 2022-2023 | Xarelto |
| Becton, Dickinson and Company | $77.59 | 2025 | Rotarexs 6 F X 135 Cm, Lifestream, Lutonix Drug Coated Balloon |
| Organogenesis INC. | $71.49 | 2023-2025 | Puraply Wound Matrix, Puraply |
| Smith+Nephew, INC. | $60.28 | 2022-2023 | Stravix |
| Cagent Vascular INC | $55.15 | 2022 | |
| Tactile Systems Technology INC | $37.83 | 2024 | Entre Plus, Flexitouch Plus |
| Ethicon US, LLC | $23.15 | 2019 | |
| Kci USA, INC. | $16.17 | 2023 | Prevena, V.A.C. Veraflo, Cavilon |
| Kerecis Limited | $14.94 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| E.R. Squibb & Sons, L.L.C. | $13.81 | 2023 | Camzyos |
| Pfizer INC. | $11.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thekla Bacharach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.